Trial results for a study on "Healthcare Disparities in Alopecia Areata" were posted on ClinicalTrials.gov on 2025-06-18. The study, which included a large population, found that individuals with Alopecia Areata had an odds ratio of 1.35 for depressive episodes compared to those without the condition.
Background
Alopecia areata (AA) is a common immune-mediated condition characterized by non-scarring hair loss. It is frequently associated with significant morbidity, impacting patients' quality of life. Despite its prevalence, comprehensive population-based data on potential disparities in the burden of AA, particularly across different ethnicities and socioeconomic statuses, have been limited. Furthermore, AA is known to be associated with an increased burden of mental health conditions and can affect work-related outcomes such as unemployment and time off work. A detailed understanding of these burdens is crucial for addressing healthcare disparities and improving patient care.
Trial design
This completed, large-scale, population-based study enrolled 4,052,231 participants to investigate healthcare disparities in Alopecia Areata. The study focused on individuals with Alopecia Areata and a reference group without the condition. As an observational study, it did not involve specific interventions or a designated trial phase. Its primary aim was to provide population-based estimates of the lifetime risk of AA and to understand the burden of the disease, including its association with mental health conditions and healthcare utilization.
Key results
The study's results highlighted several key differences in mental health outcomes and healthcare utilization between people with and without Alopecia Areata:
- For depressive episodes, 1217 participants with Alopecia Areata experienced them, compared to 3576 participants in the reference group. The analysis showed an Odds Ratio (OR) of 1.35 (95% CI: 1.25 to 1.46) for depressive episodes in individuals with Alopecia Areata.
- Regarding recurrent major depressive disorder, 835 participants with Alopecia Areata were affected, versus 2264 in the reference group. The Odds Ratio (OR) was 1.45 (95% CI: 1.32 to 1.58).
- Anxiety disorder was observed in 1113 participants with Alopecia Areata and 3188 in the reference group. The Odds Ratio (OR) for anxiety disorder was 1.4 (95% CI: 1.3 to 1.51).
- In terms of healthcare utilization, people with Alopecia Areata had 39034 primary care attendances, while the reference group had 109052. The Incidence rate ratio (IRR) for primary care attendances was 1.42 (95% CI: 1.37 to 1.46).
- Dermatology referrals were significantly higher for those with Alopecia Areata, with 1352 referrals compared to 743 in the reference group. The Hazard Ratio (HR) for dermatology referrals was notably high at 8.26 (95% CI: 7.55 to 9.04).
- Psychological therapy visits were recorded for 248 participants with Alopecia Areata and 672 in the reference group. The Hazard Ratio (HR) for psychological therapy was 1.36 (95% CI: 1.17 to 1.57).
What this means
These findings underscore a significant burden of mental health conditions, including depressive episodes and anxiety disorders, among individuals with Alopecia Areata. The increased odds ratios for these conditions suggest that patients with AA may require proactive screening and support for psychological well-being. The substantially higher hazard ratio for dermatology referrals highlights the specific dermatological care needs of this patient population. While primary care attendances and psychological therapy visits also showed increased incidence, the magnitude was less pronounced than for dermatology referrals. Overall, the results indicate that Alopecia Areata is associated with a considerable impact on mental health and increased utilization of specific healthcare services, emphasizing the importance of integrated care approaches that address both the physical and psychological aspects of the condition.
Source
The information regarding these study results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT05727306, titled "Healthcare Disparities in Alopecia Areata", were posted on 2025-06-18 on clinicaltrials.gov.